INSIGHTS ON CLINICAL TRIAL DESIGN
-
Mastering Precision Oncology Start-Up: Reducing Screening Delays
Biomarker-driven trials create intricate screening hurdles. Explore creative, practical ways to accelerate start‑up, boost enrollment, and power precision oncology studies forward with greater speed.
-
A Global Framework For Participant Engagement, Retention & Trial Success
Explore how clinical operations leaders can close the global retention gap by designing experiences that feel genuinely local, from how participants are paid to how they’re supported day to day.
-
The Neural Crystal Ball: Forecasting Future CNS Drug Development
Advances in the industry are redefining how we treat neurological and psychiatric disorders. In this presentation, Dr. Beatrice Setnik examines the trends and innovations shaping the next generation of therapies.
-
Community Connections: Leveraging Localized Patient Access In Clinical Trials
This roundtable brought together several experts to discuss how expanding community-based research can transform clinical trial recruitment and representation.
-
5 Common Misconceptions About Mobile Visits In Clinical Trials10/11/2024
In this article, we address five key misconceptions about mobile research services, including concerns about inconsistent nurse assignments, privacy risks, and limited applications for complex protocols.
-
Recruitment To Screening: Bridging The Gap12/5/2025
Explore how providing tracked transportation for patients can streamline recruitment, improve site conversion rates, and deliver measurable ROI for clinical trials.
-
Bring RTSM In A Protocol Synopsis: Here's Why3/25/2026
Learn how early feedback from experienced teams can reveal hidden protocol and logistical risks, helping sponsors refine decisions and avoid avoidable challenges long before the final protocol is set.
-
Clinical Trials Need To Take The Whole Patient Into Account7/10/2025
Explore how inclusivity in clinical trials needs to encompass the whole patient, taking into account factors like race, sex, age, ethnicity, sexual orientation, and physical abilities or qualities.
-
Reducing The Burden Of Patient Retention And Improving Continuity1/6/2026
Immunology trials often place a sustained burden on participants. However, integrating Home Trial Support (HTS) into a Phase 3 immunology trial can help improve the overall study experience.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Explore an innovative, automated approach that streamlines processes, strengthens financial controls, and accelerates readiness for Equity Events/Sox Controls, and much more.
-
Altasciences’ pain experts and neuroscientists are here to guide you in selecting the most appropriate pain model to successfully evaluate the efficacy and safety profile of your study drug.
-
Clinical trials often fail due to poor feasibility planning. A new AI-powered approach bridges protocol design with real-world patient access to improve enrollment success.
-
Accelerate trial timelines and recruitment while reducing site burden through this site network solution.
-
Dedicated Patient Liaison support helps coordinate participant travel, reimbursements, and visit logistics so sites stay focused and study requests keep moving forward.